ASX Mkt. Sensitive<p>PYC Therapeutics ( <a href="https://mastodon-grafa.social/tags/PYC" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>PYC</span></a> ) has released " Approval to Escalate Dosing in Kidney Disease Trial " on Mon 26 May at 09:13 AEST <a href="https://mastodon-grafa.social/tags/today" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>today</span></a> <a href="https://mastodon-grafa.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ClinicalTrials</span></a> <a href="https://mastodon-grafa.social/tags/Australia" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Australia</span></a> <a href="https://mastodon-grafa.social/tags/media" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>media</span></a> <a href="https://mastodon-grafa.social/tags/live" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>live</span></a> <br><a href="https://grafa.com/asset/pyc-therapeutics-ltd-3821-pyc.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=pyc.asx" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">grafa.com/asset/pyc-therapeuti</span><span class="invisible">cs-ltd-3821-pyc.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=pyc.asx</span></a></p>